These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9387889)

  • 1. Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus.
    Connor B; Beilharz EJ; Williams C; Synek B; Gluckman PD; Faull RL; Dragunow M
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):283-90. PubMed ID: 9387889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor is reduced in Alzheimer's disease.
    Connor B; Young D; Yan Q; Faull RL; Synek B; Dragunow M
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):71-81. PubMed ID: 9387865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocytes associated with senile plaques possess muscarinic acetylcholine receptors.
    Messamore E; Bogdanovich N; Schröder H; Winblad B
    Neuroreport; 1994 Jul; 5(12):1473-6. PubMed ID: 7948841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor alpha-immunoreactive astrocytes are increased in the hippocampus in Alzheimer's disease.
    Lu YP; Zeng M; Hu XY; Xu H; Swaab DF; Ravid R; Zhou JN
    Exp Neurol; 2003 Oct; 183(2):482-8. PubMed ID: 14552888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial fibrillary acidic protein and Alzheimer's disease.
    Panter SS; McSwigan JD; Sheppard JR; Emory CR; Frey WH
    Neurochem Res; 1985 Dec; 10(12):1567-76. PubMed ID: 4088432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of nuclear factor and inflammatory chemotactic factors in brain of patients with Alzheimer's disease].
    Liao Y; Guan ZZ; Ravid R
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):585-9. PubMed ID: 22177240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytes and the plaques of Alzheimer's disease.
    Mandybur TI; Chuirazzi CC
    Neurology; 1990 Apr; 40(4):635-9. PubMed ID: 1690867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I and its receptor in the frontal cortex, hippocampus, and cerebellum of normal human and alzheimer disease brains.
    Jafferali S; Dumont Y; Sotty F; Robitaille Y; Quirion R; Kar S
    Synapse; 2000 Dec; 38(4):450-9. PubMed ID: 11044892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques.
    Sheng JG; Mrak RE; Griffin WS
    J Neurosci Res; 1994 Nov; 39(4):398-404. PubMed ID: 7884819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactive epidermal growth factor receptors in neuritic plaques from patients with Alzheimer's disease.
    Birecree E; Whetsell WO; Stoscheck C; King LE; Nanney LB
    J Neuropathol Exp Neurol; 1988 Sep; 47(5):549-60. PubMed ID: 3049945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: association with pathology.
    Anderson AJ; Cummings BJ; Cotman CW
    Exp Neurol; 1994 Feb; 125(2):286-95. PubMed ID: 8313943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytes upregulate glial fibrillary acidic protein (GFAP), but not insulin-like growth factor-I (IGF-I) during experimental autoimmune neuritis (EAN).
    Gehrmann J; Yao DL; Bonetti B; Brenner M; Bondy C; Wekerle H; Kreutzberg GW; Webster Hde F
    Brain Pathol; 1995 Jan; 5(1):1-10. PubMed ID: 7539325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
    Yu WF; Guan ZZ; Bogdanovic N; Nordberg A
    Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early neuronal accumulation of DNA double strand breaks in Alzheimer's disease.
    Shanbhag NM; Evans MD; Mao W; Nana AL; Seeley WW; Adame A; Rissman RA; Masliah E; Mucke L
    Acta Neuropathol Commun; 2019 May; 7(1):77. PubMed ID: 31101070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
    Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
    Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
    Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS
    Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological diversities of CD44 positive astrocytes in the cerebral cortex of normal subjects and patients with Alzheimer's disease.
    Akiyama H; Tooyama I; Kawamata T; Ikeda K; McGeer PL
    Brain Res; 1993 Dec; 632(1-2):249-59. PubMed ID: 7511977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions.
    Rebeck GW; Reiter JS; Strickland DK; Hyman BT
    Neuron; 1993 Oct; 11(4):575-80. PubMed ID: 8398148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial fibrillary acidic protein (GFAP) immunohistochemistry in human cortex: a quantitative study using different antisera.
    Halliday GM; Cullen KM; Kril JJ; Harding AJ; Harasty J
    Neurosci Lett; 1996 May; 209(1):29-32. PubMed ID: 8734902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of the TIAR protein in the hippocampus of Alzheimer patients.
    Oleana VH; Salehi A; Swaab DF
    Neuroreport; 1998 May; 9(7):1451-4. PubMed ID: 9631446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.